Company:  PUMA BIOTECHNOLOGY, INC. (PBYI)
Form Type:  8-K
Filing Date:  10/24/2012 
CIK:  0001401667 
Address:  10880 WILSHIRE BLVD.
SUITE 2150
 
City, State, Zip:  LOS ANGELES, California 90024 
Telephone:  (424) 248-6500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$77.37  
Change: 
-0.46 (-0.59%)  
Trade Time: 
Apr 24  
Market Cap: 
$2.33B
Description of Business
Unless otherwise provided in this Annual Report, references to the �Company,� �we,� �us,� and �our� refer to Puma Biotechnology, Inc., a Delaware corporation formed on April 27, 2007 and formerly known as Innovative Acquisitions Corp., together with its wholly-owned subsidiary, Puma Biotechnology Ltd., and all references to �Former Puma� refer to Puma Biotechnology, Inc., a privately-held Delaware corporation formed on September 15, 2010, that merged with and into us in October 2011. We refer to this transaction as the �Merger.� We are a development stage biopharmaceutical company with a focus on the acquisition, development and commercialization of innovative products to enhance cancer care. We aim to acquire proprietary rights to these products, by license or otherwise, fund their research and development and bring the products to market.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01 Notice of Delisting or Failure to Satisfy a ...
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 1.1
  EXHIBIT 99.1
  EXHIBIT 99.2
  EXHIBIT 99.3
  EXHIBIT 99.4
  EXHIBIT 99.5
BROKERAGE PARTNERS